FIELD: medicine.
SUBSTANCE: daily urine of the premenopausal patients suffering breast cancer is examined for a pre- and post-menopausal level of androsterone. The pre- and post-treatment androsterone contents are related to derive a ratio. If the ratio exceeds 1, breast cancer dissemination is expected for the first 2 years following the anti-tumour chemotherapy. The ratio below 1 testifies to prolonged remission.
EFFECT: use of the method enables objective patient control, planned individual therapeutic approach, with including the patients into a group of risk for intensive care and applying the measures for the well-timed treatment.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS | 2011 |
|
RU2469651C2 |
| METHOD OF PREDICTING DURATION OF RECURRENCE-FREE PERIOD IN RADICALLY TREATED PATIENTS WITH MAMMARY GLAND CANCER | 2009 |
|
RU2413231C2 |
| METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH MAMMARY CANCER | 2003 |
|
RU2251692C2 |
| METHOD OF FORECASTING RETROCESSIONS OF LARYNX CANCER | 2008 |
|
RU2389030C1 |
| METHOD FOR PREDICTING RELAPSE OF MAMMARY CANCER | 2003 |
|
RU2263319C2 |
| METHOD OF TREATMENT BREAST CANCER | 2008 |
|
RU2393888C1 |
| METHOD FOR PREDICTING RECURRENT DISEASE | 2010 |
|
RU2471191C2 |
| METHOD FOR PREDICTION OF RECURRENT VULVAR CANCER | 2013 |
|
RU2517541C1 |
| METHOD FOR TREATING THE MAMMARY GLAND CANCER | 2000 |
|
RU2188025C2 |
| METHOD OF TREATING BREAST CANCER | 2010 |
|
RU2438675C1 |
